Cancer treatment in the STI571 era: What will change?

被引：0
|
作者：
Sawyers, CL
机构：
[1] Univ Calif Los Angeles, Div Hematol Oncol, Dept Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2001年 / 19卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：13S / 16S
页数：4
相关论文
共 50 条
  • [41] Low concentrations of STI571 in the cerebrospinal fluid:: a case report
    Petzer, AL
    Gunsilius, E
    Hayes, M
    Stockhammer, G
    Duba, HC
    Schneller, F
    Grünewald, K
    Poewe, W
    Gastl, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (03) : 623 - 625
  • [42] In vitro and in vivo STI571 efficacy in neuroectodermal tumor cells
    Kronnie, GT
    Ricotti, E
    Rinaldi, A
    Creseenzio, N
    Spinelli, M
    Timeus, F
    Rosolen, A
    Basso, G
    BLOOD, 2002, 100 (11) : 220B - 220B
  • [43] STI571: A tyrosine kinase inhibitor for the treatment of CML - Validating the promise of molecularly targeted therapy
    Druker, BJ
    FASEB JOURNAL, 2002, 16 (04): : A134 - A134
  • [44] The selective tyrosine kinase inhibitor, STI571, inhibits growth of anaplastic thyroid cancer cells
    Podtcheko, A
    Ohtsuru, A
    Tsuda, S
    Namba, H
    Saenko, V
    Nakashima, M
    Mitsutake, N
    Kanda, S
    Kurebayashi, J
    Yamashita, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04): : 1889 - 1896
  • [45] The rationale engineering of BCR/ABL blockers: an answer to STI571 acquired resistance in leukemia treatment
    Majsterek, IJ
    LEUKEMIA RESEARCH, 2005, 29 (06) : 605 - 606
  • [46] Treatment of chronic myeloid leukemia (CML) with STI571 in patients age ≥60 years.
    Cortes, J
    Talpaz, M
    O'Brien, SM
    Manero, G
    Thomas, D
    Faderl, S
    Capdeville, R
    Kantarjian, HM
    BLOOD, 2001, 98 (11) : 256B - 256B
  • [47] Histopathological, cytological and cytogenetic analysis of bone marrow biopsies during treatment with STI571 (Glivec®)
    Dirnhofer, S
    Lugli, A
    Ebnoether, M
    Hurwitz, N
    Tichelli, A
    Linn, M
    Gratwohl, A
    MODERN PATHOLOGY, 2002, 15 (01) : 237A - 238A
  • [48] The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth
    Krystal, GW
    Honsawek, S
    Litz, J
    Buchdunger, E
    CLINICAL CANCER RESEARCH, 2000, 6 (08) : 3319 - 3326
  • [49] Histopathological, cytological and cytogenetic analysis of bone marrow biopsies during treatment with STI571 (Glivec®)
    Dirnhofer, S
    Lugli, A
    Ebnoether, M
    Hurwitz, N
    Tichelli, A
    Linn, M
    Gratwohl, A
    LABORATORY INVESTIGATION, 2002, 82 (01) : 237A - 238A
  • [50] STI571 inhibits the activaiton and proliferation of normal T lymphocytes.
    Cwynarski, K
    Laylor, R
    Melo, JV
    Dazzi, F
    BLOOD, 2001, 98 (11) : 256B - 257B
12345